Trials / Completed
CompletedNCT01539265
A Dose-finding Study of Silodosin in Patients With Urinary Calculi
A Randomized, Double-blind, Placebo-controlled, Phase II Study of Silodosin in Patients With Urinary Calculi
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 300 (planned)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and the safety of silodosin in urinary calculi patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | silodosin | |
| DRUG | silodosin | |
| DRUG | placebo |
Timeline
- First posted
- 2012-02-27
- Last updated
- 2013-10-30
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01539265. Inclusion in this directory is not an endorsement.